Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. We believe that everyone in need should have access to our medicines, regardless of where they live or what resources they have. Over the 15 years that we have worked in resource-limited countries, we have learned that there is no one-size-fits-all solution to access challenges. Our dedicated Global Patient Solutions (GPS) team works with public health officials, doctors and patients across 127 countries in the developing world, including all of Africa, much of Latin America and a large portion of Central, South and Southeast Asia to address barriers and opportunities in HIV, viral hepatitis and visceral leishmaniasis treatment access.